GM said in a government filing on Friday that Barra also will be eligible for $2.8 million in short-term incentives.
Her pay would climb further if GM shareholders approve a new long-term incentive plan at their next annual meeting. Stock and option awards make up the bulk of CEO pay at GM and many other publicly traded companies.
Dan Akerson, who retired as CEO Wednesday, had total 2012 pay of more than $11 million. That included a base salary of $1.7 million and $9.3 million in stock awards.
The federal government limited executive pay at GM after it took bailout money in 2008 and 2009 and the government held a stake in the company. But those restrictions were lifted after the government sold the last of its GM shares on Dec. 9.
Top 5 Oil Companies To Watch In Right Now: Hovnanian Enterprises Inc (HOV)
Hovnanian Enterprises, Inc. (Hovnanian), incorporated in 1967, designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments. The Company consists of two distinct operations: homebuilding and financial services. Its homebuilding operations consist of six segments: Northeast,including New Jersey and Pennsylvania; Mid-Atlantic, including Delaware, Maryland, Virginia, West Virginia, and Washington, D.C; Midwest, including Illinois, Minnesota and Ohio; Southeast, including Florida, Georgia, North Carolina and South Carolina; Southwest, including Arizona and Texas, and West, including California. Its financial services operations provide mortgage loans and title services to the customers of its homebuilding operations. During fiscal year ended October 31, 2011 (fiscal 2011), the Company had delivered 4,216 homes.
As of October 31, 2011, the Company was, excluding unconsolidated joint ventures, offering homes for sale in 192 communities in 37 markets in 16 states throughout the United States. It markets and builds homes for first-time buyers, first-time and second-time move-up buyers, luxury buyers, active adult buyers and empty nesters. It offers a product range to provide housing to a range of customers. Its diverse product array includes single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes.
The Company�� residential development activities include site planning and engineering, obtaining environmental and other regulatory approvals and constructing roads, sewer, water, and drainage facilities, recreational facilities and other amenities and marketing and selling homes. These activities are performed by its associates, together with independent architects, consultants, and contractors.
The Company sells its homes to customers who finance their purchases th! rough mortgages. It originates loans in Arizona, California, Delaware, Florida, Georgia, Illinois, Maryland, Minnesota, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Texas, Virginia, Washington, D.C. and West Virginia.
Advisors' Opinion:- [By John Maxfield]
Sometimes the most important data is the hardest to come by. In this case, I'm referring to historic sales figures from homebuilder Hovnanian Enterprises (NYSE: HOV ) , one of the nation's largest builders by units sold. As I've noted previously, while this is arguably the single most accurate reflection of a homebuilder's performance, not to mention the overall housing market, a comprehensive data set containing the data is nowhere to be found.
Top 10 Healthcare Technology Companies To Watch For 2014: LTX-Credence Corporation(LTXC)
LTX-Credence Corporation designs, manufactures, markets, and services automated test equipment solutions for the wireless, computing, automotive, and consumer markets. The company?s product portfolio includes Diamond platform, a package for testing microcontrollers and cost sensitive consumer devices; X-Series platform that offers configurations for optimal testing of ASSP and ASIC, power, automotive, mixed signal, and RF applications; and ASL platform, which is used for testing linear, low-end mixed signal, precision analog, and power management devices. The company also provides various services, including installation and maintenance of test systems, servicing of spare parts, parts and labor warranties on test systems, and training on the maintenance and operation of test systems. LTX-Credence Corporation sells its products through direct sales organization and distributors in the United States, Taiwan, China, Japan, Korea, and southeast Asia. The company was founded i n 1976 and is headquartered in Norwood, Massachusetts.
Advisors' Opinion:- [By CRWE]
LTX-Credence Corporation (Nasdaq:LTXC), a global provider of market focused, cost-optimized ATE solutions, reported that it will present at the Barclays Capital Global Technology, Media and Telecommunications Conference on Wednesday, May 23, 2012 at 4:15 PM EDT. This event will be available over the Internet via live webcast.
Top 10 Healthcare Technology Companies To Watch For 2014: Ishares Msci Australia Inc (EWA)
iShares MSCI Australia Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australian market, as measured by the MSCI Australia Index (the Index). The Index seeks to measure the performance of the Australian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Chad Fraser]
Another option is to buy units of an Australian exchange traded fund (ETF) like the iShares MSCI Australia Index Fund (NYSE: EWA), one of the investments we cover in Australian Edge’s How They Rate universe, which keeps over 100 Australian companies and other investments under continuous review.
Top 10 Healthcare Technology Companies To Watch For 2014: Keryx Biopharmaceuticals Inc.(KERX)
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Keryx Biopharmaceuticals (NASDAQ: KERX ) , a biopharmaceutical company focused on developing therapies to treat renal diseases, plunged as much as 12% after announcing midday Friday that Ferric Citrate (previously known as Zerenex) has been approved by the Food and Drug Administration as an oral iron-based treatment for dialysis patients with hyperphosphatemia.
- [By MONEYMORNING]
Case in point: Keryx Biopharmaceuticals (Nasdaq: KERX) is a small biotech (market cap: $1.29B) with an experimental drug, Zerenex, that treats elevated phosphate levels and iron deficiency anemia in patients on dialysis for advanced chronic kidney disease (CKD).
- [By Bryan Murphy]
If there was any doubt Keryx Biopharmaceuticals (NASDAQ:KERX) was in trouble, it was wiped away today when KERX shares moved to major lower low after logging a major lower high in December. With all the damage that's been done over the past several weeks, this weakness is now likely going to have to run its full course.
Top 10 Healthcare Technology Companies To Watch For 2014: Tredegar Corporation(TG)
Tredegar Corporation, through its subsidiaries, manufactures and sells plastic films and aluminum extrusions worldwide. The company offers apertured film and nonwoven materials for use in feminine hygiene products, baby diapers, and adult incontinence products under the SoftQuilt, ComfortAire, SoftAire, and FreshFeel names; breathable, embossed, and elastic materials for use as components for baby diapers, adult incontinence products, and feminine hygiene products under the ExtraFlex, FabriFlex, StretchTab, FlexAire, and FlexFeel names; and absorbent transfer layers for baby diapers and adult incontinence products under the AquiDry and AquiSoft names. It also provides single and multi-layer surface protection films under the UltraMask and ForceField names for protecting components of flat panel displays; a line of packaging films for food packaging and industrial applications; and apertured films, breathable barrier films, and laminates that regulate fluid or vapor transmi ssion. In addition, the company offers soft-alloy aluminum extrusions primarily for building and construction, distribution, transportation, electrical, consumer durables, and machinery and equipment markets; and manufactures mill, anodized, and painted aluminum extrusions for fabricators and distributors to produce curtain walls, storefronts, windows and doors, hurricane shutters, tub and shower enclosures, heatsinks and components for light emitting diode (LED) lighting, and automotive and light truck aftermarket parts. Further, it develops and produces microstructure-based optical films for the LED and fluorescent lighting markets; and develops, owns, and operates mitigation banks. Tredegar Corporation was founded in 1988 and is headquartered in Richmond, Virginia.
Advisors' Opinion:- [By Bryan Murphy]
It's certainly not as big as Berry Plastics Group Inc. (NYSE:BERY). It's not even as big as Tredegar Corporation (NYSE:TG). There's one big way AEP Industries (NASDAQ:AEPI) can certainly compete head-on with BERY and TG right now, however... as an investment opportunity. Thanks to the bullish bump AEPI gave us last week, a long-standing selloff has been revered, and there's a whole lot of ground to make up.
Top 10 Healthcare Technology Companies To Watch For 2014: LendingClub Corp (LC)
LendingClub Corporation, incorporated on October 2, 2006, provides online marketplace connecting borrowers and investors. The Company operates an online market that connects borrowers looking for loans with individuals with the money to fund them. It lends money to help consumers pay off credit-card bills, consolidate debt and take vacations. Its platform enables customers in investing in and obtaining personal loans by providing financial data and credit information.
The Company provides search algorithm, credit decisioning, a secondary market, and a choice of loan durations. The Company serves the professional fixed income investors, such as family offices and insurance companies.
Advisors' Opinion:- [By Rana Pritanjali]
Lending Club's (NYSE: LC ) stock is up a stellar 66% since the company went public in December. The peer-to-peer lending specialist offers an alternative to the traditional banking system with an online platform for borrowers and lenders. It has a leading 40% share of the�peer-to-peer lending market, far outstripping No. 2 player�Prosper.com and its 8% market share.�
Top 10 Healthcare Technology Companies To Watch For 2014: Imperva Inc (IMPV)
Imperva, Inc. (Imperva), incorporated on April 2002, is engaged in providing data security solutions focused on providing visibility and control over business data across systems within the data center. The Company�� securesphere data security suite is a solution designed to prioritize and mitigate risks to high-value business data, protect against hackers and malicious insiders and address and streamline regulatory compliance. SecureSphere is an integrated, modular suite, which provides database, file and Web application security and secures all business data across a range of systems in data centers, including traditional on-premise data centers as well as private, public and hybrid cloud computing environments. The Company also offers on-demand, cloud-based security services. The Company has two segments: Imperva, which is comprised of its financial position and results of operations and those of the Company�� wholly owned subsidiaries, and Incapsula, which is comprised of the financial position and results of operations of the Company�� majority owned subsidiary. In February 2014, Imperva Inc acquired real-time mainframe security auditing agents from Tomium Software.
The Company�� products include SecureSphere data security suite for enterprise data centers and its cloud-based security services that it provides through Incapsula for mid-market enterprises and small and medium business (SMBs). The Company�� solution includes database security, file security and Web application security.
Database Security
Database security provides full visibility and control over structured business data repositories, including database data usage, vulnerabilities and access rights and enables security, audit, risk and information technology (IT) professionals to improve data security and address compliance requirements. The database products cover the enterprise database platforms, including Oracle, MS-SQL, IBM DB2, Sybase, Informix, MySQL, Progress, Teradata and ! Netezza. The database security products include discovery and assessment server, database activity monitoring, database firewall, user rights management for databases and analog-to-digital converter (ADC) insights. The discovery and assessment server automates the process of discovering databases and other business data on the network and performs a security assessment to identify risks to high-value business data. Database activity monitoring includes all discovery and assessment server functionality. Database firewall includes database activity monitoring functionality. User rights management for databases enables the management of user rights across heterogeneous enterprise databases by aggregating user rights to illustrate what rights users have to business data. ADC Insights provides user tracking for identifying the real end user behind database transactions.
The Company competes with International Business Machines Corporation, McAfee, Inc. and Oracle Corporation.
File Security
File security provides full visibility and control over unstructured business data repositories, including file ownership, usage and access rights and enables security, audit, risk and information technology (IT) professionals to improve file data security and address compliance requirements. The file security products are designed to secure files, including spreadsheets, presentation slides, word processing documents and portable document format (PDFs) containing high-value business data that its customers store in unstructured repositories, such as file servers, network attached storage and storage area network devices. The File security products include user rights management for files, file activity monitoring and file firewall. User rights management for files enables the management of user access rights across multiple different file storage systems by aggregating user rights based on organizational context and actual file usage to illustrate what rights users have to sensitive ! files. Fi! le activity monitoring includes all user rights management for files functionality. File firewall includes all file activity monitoring functionality, and provides real-time blocking of suspicious activity that violates corporate policies.
The Company competes with EMC Corporation and Symantec Corporation.
Web Application Security
Web application security protects Web applications from large scale cyber attacks, adapts to evolving threats to prevent data breaches and addresses compliance requirements. Its product includes Web application firewall (WAF), which fortifies Web defenses with research-driven intelligence on current threats.
The Company competes with Citrix Systems, Inc. and F5 Networks, Inc.
Cloud-Based Services
The Company�� cloud-based service offerings are its Incapsula service, the Imperva Cloud WAF Service and its ThreatRadar subscription service. The Incapsula service is designed to be easy to deploy and to be accessible to small and medium size businesses that need data security and compliance solutions, but do not have the size or resources to deploy its SecureSphere WAF appliances into their own Website infrastructure. Incapsula�� security and optimization offerings include the services, including Web application firewall services, content delivery optimization and distributed denial of service-attack prevention. Web application firewall services provide enterprise-grade blocking of attacks against Web applications to help ensure Website safety and availability; enhanced security through real-time and centralized threat detection across all protected Websites; allows customers to address compliance requirements. Content delivery optimization optimizes Website performance by reducing page load times, server load and bandwidth consumption. Distributed denial of service-attack prevention blocks malicious attack traffic and allows filtered, legitimate traffic to flow to the customer Website allowing its b! usiness t! o run without interruption.
Imperva Cloud WAF powered by Incapsula, bundles the incapsula service with managed support services from our security operations center (SOC). Managed services include provisioning, security alert notifications and tuning, incident response, real time service dashboard and statistics, customer support and weekly reports on alerts and attack trends. ThreatRadar is an add-on, premium subscription service for the Company�� SecureSphere WAF appliance that recognizes attack sources and dynamically adjusts Web security policies within its SecureSphere WAF appliance to provide protection against them.
The customers include four of the telecommunications companies, three of the commercial banks in the United States, three of the financial data service firms, three of the computer hardware companies, two of the food and drug store companies, over 150 government agencies worldwide and more than 100 Fortune 1000 companies. The Company primarily sells its products and services through its network of over 350 channel partners worldwide, including both distributors and resellers. The Company derives its revenue from sales and licenses of its products and sales of its services. Services revenue consists of maintenance and support, professional services and training and subscriptions. A majority of the Company�� revenue is derived from customers in the Americas region. As of December 31, 2010, 66% of its total revenue was generated from the Americas, 24% from Europe, Middle East and Africa (EMEA) and 10% from Asia Pacific, and for the six months ended June 30, 2011, 63% of its total revenue was generated from the Americas, 24% from EMEA and 13% from Asia Pacific.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Imperva (NYSE: IMPV) were down 38.35 percent to $30.66 after the company cut its first-quarter outlook. Imperva now expected a loss of $0.40 to $0.44 per share, on revenue of $31 million to $31.5 million. - [By Monica Gerson]
Imperva (NYSE: IMPV) shares tumbled 41.52% to touch a new 52-week low of $29.08 after the company cut its first-quarter outlook. Imperva now expected a loss of $0.40 to $0.44 per share, on revenue of $31 million to $31.5 million.
No comments:
Post a Comment